首頁 > 市場調查報告書 > 醫療設備

體外診斷

快速醫療診斷試劑盒市場規模、佔有率和成長分析（按產品、技術、應用、最終用途和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1897965

快速醫療診斷試劑盒市場規模、佔有率和成長分析（按產品、技術、應用、最終用途和地區分類）—產業預測（2026-2033 年）

Rapid Medical Diagnostic Kits Market Size, Share, and Growth Analysis, By Product (Over the Counter (OTC) Kits, Professional Kits), By Technology (Lateral Flow, Agglutination), By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，快速醫療診斷試劑盒市場規模將達到 172.4 億美元，到 2025 年將達到 178.2 億美元，到 2033 年將達到 232.9 億美元，預測期（2026-2033 年）的複合年成長率為 3.4%。

由於包括呼吸道感染疾病在內的感染疾病率不斷上升，全球快速醫療診斷試劑盒市場正經歷強勁成長。這些試劑盒在感染疾病的大規模檢測和快速識別中發揮關鍵作用，有助於有效控制疾病，因此市場需求激增。技術進步進一步提升了這些診斷工具的效能，提高了其準確性、靈敏度和易用性，這在資源匱乏地區和醫療照護現場尤其重要。然而，該市場也面臨著許多挑戰，例如嚴格的監管要求和品管問題，這些挑戰必須克服才能確保結果的可靠性。此外，企業也面臨日益激烈的競爭，需要持續投資於研發，以實現創新並滿足不斷變化的醫療需求。

快速醫療診斷試劑盒市場促進因素

包括新冠肺炎、流感、愛滋病和各種性行為感染傳染病在內的感染疾病日益流行，推動了對快速醫療診斷試劑盒的需求。這些試劑盒能夠快速且準確地檢測病原體，從而實現疾病的早期識別和適當治療。這種需求的激增反映了人們對能夠提供即時結果的高效醫療解決方案的迫切需求，這對於控制疫情爆發和保障病人安全至關重要。隨著醫療系統將快速診斷置於優先地位，這些試劑盒的市場持續擴大，凸顯了它們在現代醫療實踐和疾病管理中的重要性。

快速醫療診斷試劑盒市場限制因素

快速醫療診斷試劑盒市場面臨許多限制因素，其中最主要的限制因素是嚴格的監管標準，這些標準對於確保產品的安全性、準確性和可靠性至關重要。獲得必要的監管核准並確保持續合規的過程耗時耗力，成本高昂。這為市場准入設置了巨大的障礙，尤其對於那些可能缺乏資源來應對這些複雜要求的小型製造商而言更是如此。因此，這可能會阻礙市場成長潛力，限制行業內的創新和競爭，並最終影響消費者獲得多樣化診斷解決方案的機會。

快速醫療診斷試劑盒市場趨勢

快速醫療診斷試劑盒市場正經歷著向攜帶式、易用型設備的顯著轉變，這主要得益於對高效就地檢驗的需求，尤其是在偏遠、資源匱乏的地區。這一趨勢凸顯了直覺設計和清晰說明的重要性，使這些設備能夠被醫療專業人員和消費者輕鬆使用。遠端醫療和居家醫療保健的興起進一步推動了這一需求，因為易於使用的診斷試劑盒使用戶只需接受極少的培訓即可進行檢測。因此，設計和功能方面的創新對於改善患者預後和促進即時決策至關重要。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- 雅培實驗室（美國）
- ACON 實驗室公司（美國）
- Alfa Scientific Designs Inc.（美國）
- Artron Laboratories Inc.（加拿大）
- F. Hoffmann-La Roche Ltd.（瑞士）
- 貝克頓·迪金森公司（美國）
- 生物梅里埃公司（法國）
- BTNX 公司（加拿大）
- Creative Diagnostics（美國）
- 丹納赫公司（美國）
- 西門子醫療有限公司（德國）
- Bio-Rad Laboratories Inc.（美國）
- 康德樂（美國）
- Meridian Bioscience Inc.（美國）
- Zoetis Inc.（美國）
- 麥克森醫療外科公司（美國）
- Trinity BIoTech（愛爾蘭）
- Hologic公司（美國）
- Atlas Link BIoTech Co. Ltd.（中國）
- SD Biosensor Inc.（韓國）

結論與建議

簡介目錄

Product Code: SQMIG35A2655

Rapid Medical Diagnostic Kits Market size was valued at USD 17.24 Billion in 2024 and is poised to grow from USD 17.82 Billion in 2025 to USD 23.29 Billion by 2033, growing at a CAGR of 3.4% during the forecast period (2026-2033).

The global market for rapid medical diagnostic kits is experiencing robust growth, fueled by the rising incidence of infectious diseases, including respiratory infections. The demand for these kits has surged as they play a pivotal role in mass testing and rapid identification of infections, aiding in effective disease management. Technological advancements have further enhanced the performance of these diagnostic tools, improving accuracy, sensitivity, and usability, which is particularly beneficial in resource-limited environments and point-of-care settings. However, the market faces challenges, including stringent regulatory requirements and quality control issues that must be addressed to ensure reliable results. Companies are also contending with intensified competition, necessitating ongoing investment in research and development to innovate and meet dynamic healthcare demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Rapid Medical Diagnostic Kits market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Rapid Medical Diagnostic Kits Market Segments Analysis

Global Rapid Medical Diagnostic Kits Market is segmented by product, technology, application, end use and region. Based on product, the market is segmented into over the counter (OTC) kits and professional kits. Based on technology, the market is segmented into lateral flow, agglutination, solid phase and other technologies. Based on application, the market is segmented into blood glucose testing, infectious disease testing, cardiometabolic testing, pregnancy & fertility testing, fecal occult blood testing, coagulation testing, toxicology testing, lipid profile testing and other applications. Based on end use, the market is segmented into hospitals & clinics, home care, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Rapid Medical Diagnostic Kits Market

The increasing prevalence of infectious diseases, including COVID-19, influenza, HIV, and various sexually transmitted infections, is driving the demand for rapid medical diagnostic kits. These kits offer fast and precise pathogen detection, allowing for timely identification and management of illnesses. This surge in demand is reflective of the need for efficient healthcare solutions that can provide immediate results, which is crucial in controlling outbreaks and ensuring patient safety. As healthcare systems prioritize rapid diagnostics, the market for these kits continues to expand, emphasizing their importance in modern medical practice and disease management.

Restraints in the Rapid Medical Diagnostic Kits Market

The market for rapid medical diagnostic kits faces significant constraints due to the stringent regulatory standards that are essential for guaranteeing safety, accuracy, and reliability. The processes involved in obtaining the necessary regulatory approvals and ensuring ongoing compliance can be both lengthy and costly. This creates substantial barriers to market entry, particularly for smaller manufacturers who may lack the resources to navigate these complex requirements. As a result, the growth potential of the market may be stunted, limiting innovation and competition within the industry, ultimately affecting the availability of varied diagnostic solutions for consumers.

Market Trends of the Rapid Medical Diagnostic Kits Market

The Rapid Medical Diagnostic Kits market is witnessing a notable shift towards portable and user-friendly devices, driven by the need for efficient point-of-care testing, especially in resource-limited and remote settings. This trend emphasizes the importance of intuitive designs and clear instructions, making these devices accessible for both healthcare professionals and consumers. The rise of telemedicine and home healthcare has further accelerated this demand, as easy-to-use diagnostic kits empower users to perform tests with minimal training. As a result, innovation in design and functionality is crucial in enhancing patient outcomes and facilitating quicker decision-making in medical care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Trade Analysis
Customer & Buying Criteria Analysis

Global Rapid Medical Diagnostic Kits Market Size by Product & CAGR (2026-2033)

Market Overview
Over The Counter (OTC) Kits
Professional Kits

Global Rapid Medical Diagnostic Kits Market Size by Technology & CAGR (2026-2033)

Market Overview
Lateral Flow
Agglutination
Solid Phase
Other Technologies

Global Rapid Medical Diagnostic Kits Market Size by Application & CAGR (2026-2033)

Market Overview
Blood Glucose Testing
Infectious Disease Testing
- Covid-19
- Hepatitis
- HIV
- Influenza
- Others
Cardiometabolic Testing
Pregnancy & Fertility Testing
Fecal Occult Blood Testing
Coagulation Testing
Toxicology Testing
Lipid Profile Testing
Other Applications

Global Rapid Medical Diagnostic Kits Market Size by End Use & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Home Care
Diagnostic Laboratories
Others

Global Rapid Medical Diagnostic Kits Market Size & CAGR (2026-2033)

North America (Product, Technology, Application, End Use)
- US
- Canada
Europe (Product, Technology, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Technology, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Technology, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Technology, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACON Laboratories Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Scientific Designs Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Artron Laboratories Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BTNX Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Diagnostics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthcare GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
McKesson Medical-Surgical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Atlas Link Biotech Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SD Biosensor Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments